fda warning bpc-157 unapproved drug 2024 panel narrowly backs peptide touted by Joe Rogan An FDA advisory committee voted

An FDA advisory committee voted Thursday to remove compounding restrictions on four peptides despite little evidence the products are safe or effective for medical use. In a series of 8 6 votes (with FDA panel backs compounded BPC 157, KPV peptides in win for RFK Jr. STAT The experts will take votes on whether the FDA should allow seven popular peptides to be added to a list of substances that are safe for compounding by pharmacies. The FDA is reviewing which compounded peptides will be permitted for production by specialized pharmacies, threatening consumer access. MORE BELOW FDA panel considers loosening regulations for some peptides Advisers to the FDA back broad access to unapproved peptides, despite agency concerns

SKU: 36651076996 · From elitechmx.com